Kamada Provides 2026 Annual Guidance of $200 – $205 Million in Revenues and $50 – $53 Million of Adjusted EBITDA, Representing Double-Digit Growth and Affirms 2025 Financial Guidance

Kamada Provides 2026 Annual Guidance of $200 – $205 Million in Revenues and $50 – $53 Million of Adjusted EBITDA, Representing Double-Digit Growth and Affirms 2025 Financial Guidance GlobeNewswire January 07, 2026 2026 Guidance Represents Year-Over-Year Increase of 13% in Revenues and 23% in Adjusted EBITDA Based on Mid-Point of 2025 Annual Guidance 2026 Annual […]

OTC Markets Group Welcomes FUTURE FUELS INC to OTCQX

OTC Markets Group Welcomes FUTURE FUELS INC to OTCQX GlobeNewswire January 07, 2026 NEW YORK, Jan. 07, 2026 (GLOBE NEWSWIRE) — OTC Markets Group Inc. (OTCQX: OTCM), operator of regulated markets for trading 12,000 U.S. and international securities, today announced FUTURE FUELS INC (TSX-V: FTUR; OTCQX: FTURF), a Canadian mineral exploration and development company, has

Liquidia Corporation to Present at 44th Annual J.P. Morgan Healthcare Conference

Liquidia Corporation to Present at 44th Annual J.P. Morgan Healthcare Conference GlobeNewswire January 07, 2026 MORRISVILLE, N.C., Jan. 07, 2026 (GLOBE NEWSWIRE) — Liquidia Corporation (NASDAQ: LQDA) announced today that Dr. Roger Jeffs, Chief Executive Officer, will present at the 44th Annual J.P. Morgan Healthcare Conference on Wednesday, January 14, 2026 beginning at approximately 5:15

Avance Clinical Strengthens Global Oncology Offering with Acquisition of U.S.-Based LumaBridge and Establishes New Oncology Center of Excellence

Avance Clinical Strengthens Global Oncology Offering with Acquisition of U.S.-Based LumaBridge and Establishes New Oncology Center of Excellence GlobeNewswire January 07, 2026 ADELAIDE, Australia, Jan. 07, 2026 (GLOBE NEWSWIRE) — Avance Clinical, a global contract research organization focused on accelerating clinical development for biotech sponsors, today announced the acquisition of LumaBridge, a specialized U.S.-based clinical

JJP Biologics Announces Positive Top-Line Phase I Trial Results of JJP-1212, its anti-CD89 antagonist

JJP Biologics Announces Positive Top-Line Phase I Trial Results of JJP-1212, its anti-CD89 antagonist GlobeNewswire January 07, 2026 Favorable safety, tolerability, pharmacokinetic and pharmacodynamic profiles validate and significantly de-risk the program Supports the feasibility of intravenous and subcutaneous dosing regimens in upcoming clinical development stages Confirms JJP-1212 as a versatile antibody with potential for use

Rumble and Tether Launch Crypto Wallet for Creator Economy

Rumble and Tether Launch Crypto Wallet for Creator Economy GlobeNewswire January 07, 2026 LONGBOAT KEY, Fla., Jan. 07, 2026 (GLOBE NEWSWIRE) — Rumble Inc. (NASDAQ:RUM), the Freedom-First technology platform, and Tether, the largest company in the digital assets industry, today launched the Rumble Wallet, a non-custodial crypto wallet integrated directly into the Rumble platform. At

Automotive innovation through open collaboration: momentum builds around open source software as a key driver of efficiency and success

Automotive innovation through open collaboration: momentum builds around open source software as a key driver of efficiency and success Eclipse SDV and VDA bring together 32 automotive industry leaders to drive open collaboration for software-defined mobility, delivering up to 40% reductions in development and maintenance effort and up to 30% faster time to market GlobeNewswire

YieldMax(R) ETFs Announces Weekly Distributions for Group 2 ETFs

CHICAGO, MILWAUKEE, and NEW YORK, Jan. 07, 2026 (GLOBE NEWSWIRE) — YieldMax(R) ETFs today announced distributions for the YieldMax(R) Group 2 weekly pay ETFs. Group 2 Distribution Announcement Ex. & Record Date: January 8, 2026Payment Date: January 9, 2026 ETFTicker1 ETF Name DistributionFrequency Distribution perShare DistributionRate2,4 30-DaySEC Yield3 ROC5 ABNY YieldMax(R) ABNB Option Income Strategy

YieldMax(R) ETFs Announces Weekly Distributions for Group 2 ETFs

YieldMax(R) ETFs Announces Weekly Distributions for Group 2 ETFs GlobeNewswire January 07, 2026 CHICAGO, MILWAUKEE, and NEW YORK, Jan. 07, 2026 (GLOBE NEWSWIRE) — YieldMax(R) ETFs today announced distributions for the YieldMax(R) Group 2 weekly pay ETFs. Group 2 Distribution Announcement Ex. & Record Date: January 8, 2026Payment Date: January 9, 2026 ETFTicker1 ETF Name

Functional Pet Food Market Size to Worth USD 7 Billion by 2035 | Towards FnB

Functional Pet Food Market Size to Worth USD 7 Billion by 2035 | Towards FnB According to Towards FnB, the global functional pet food market size is evaluated at USD 3.35 billion in 2026 and is projected to reach USD 7 billion by 2035, reflecting a robust CAGR of 8.54% from 2026 to 2035. This

Scroll to Top